David Flores

Co-Founder, President & CEO
BioCentury

David Flores has devoted more than 30 years to developing business intelligence services for biopharma executives and investors. He is the architect of BioCentury’s global platform of analysis, data and executive conferences.
In 2024, BayHelix, the association of life science business leaders in the U.S. and China, awarded David its Lifetime Achievement award for his efforts championing cross-border collaboration and global drug development.
In 1996, David and BioCentury Co-Founder & Chairman Karen Bernstein, Ph.D., were honored with the Special Recognition Award given by the annual gathering of biotechnology chief executive officers in Laguna Niguel, Calif., citing BioCentury's contributions to the industry.
David has served as a member of the Advisory Board of the Innovation and New Ventures Office (INVO) at Northwestern University and served for many years on the Advisory Council of the Keck Graduate Institute of the Applied Life Sciences. He also has served as a member of the Stanford Graduate School of Business Management Board.
David is a graduate of the University of California at Berkeley and holds an MBA from Stanford University.​


​

Speech title & Synopsis

Biotech’s Complex Moment

Biopharma companies and investors are racing to source Asian assets for newcos in the West even as geopolitical tensions challenge globalization of science, data sharing and cross-border talent exchange. At the same time, access to capital is perhaps historically difficult. Going forward, the question is how can innovators and investors rise to the complexity of the moment?